Investigating the Unique Immunological and Virological Characteristics of Hepatitis B in Special Populations

Simple item page
dc.contributor.advisorCoffin, Carla
dc.contributor.authorPatel, Nishi Harishkumar
dc.contributor.committeememberVan Marle, Guido
dc.contributor.committeememberSycuro, Laura
dc.contributor.committeememberPatel, Trushar
dc.date2024-11
dc.date.accessioned2024-07-11T15:49:56Z
dc.date.available2024-07-11T15:49:56Z
dc.date.issued2024-07-04
dc.description.abstractThe hepatitis B virus (HBV) causes acute and chronic hepatitis B (CHB) infection. Most immunocompetent adults develop self-limiting acute hepatitis B and serum HBV surface antigen (HBsAg) clearance due to robust innate and adaptive anti-viral immune responses. If acute hepatitis B does not resolve within six months, with persistence of HBsAg in serum, it is diagnosed as CHB infection. In both acute and CHB, HBV covalently closed circular (ccc) DNA and integrated viral genome in host chromosomes persist within the hepatocyte and increase the risk of occult hepatitis B infection (OBI). Rarely, an exacerbated host anti-viral immune response and a cytokine storm can lead to acute liver failure (ALF). CHB is associated with high levels of subviral particles (i.e., HBsAg), suppression of innate immunity, and peripheral tolerance marked by T cell exhaustion. A cure for CHB will reduce the liver disease burden and need for lifelong anti-viral therapy. A complete (sterilizing) cure requires eradication of the HBV cccDNA reservoir and integrated viral genomes but is difficult to achieve. Thus, a functional cure that enhances host anti-viral immune response and clearance of HBsAg is the goal of new therapeutic approaches. We prospectively recruited three unique patient populations to investigate viral and/or immune factors associated with varying immune control of HBV infection: (i.e., OBI and human immunodeficiency virus co-infection, CHB and metabolic-dysfunction associated steatotic liver disease, and HBV induced ALF).We assessed standard and novel viral biomarkers, viral variants by Sanger and deep sequencing, serum cytokines and/or peripheral HBV specific T cell response by enzyme-linked immunosorbent spot assay (ELISpot). Complementary studies were performed in a transgenic mouse model of HBV. We found unique HBV variants associated with host immune escape, risk of reactivation, liver fibrosis and hepatocellular carcinoma development, which varied between patient cohorts. Patients with greater hepatic steatosis and metabolic syndrome displayed heightened pro-inflammatory cytokines, HBV-specific T cell responses, and suppression of HBV replication. Increased serum angiogenic factors were associated with improved prognosis (i.e., reduced need for liver transplant) in individuals with ALF. In conclusion, unique HBV variants and dynamic host anti-viral immune response are associated with reduced viremia and positive clinical outcomes in individuals with hepatitis B infection.
dc.identifier.citationPatel, N. H. (2024). Investigating the unique immunological and virological characteristics of hepatitis B in special populations (Doctoral thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca.
dc.identifier.urihttps://hdl.handle.net/1880/119136
dc.identifier.urihttps://doi.org/10.11575/PRISM/46732
dc.language.isoen
dc.publisher.facultyGraduate Studies
dc.publisher.institutionUniversity of Calgary
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.
dc.subjectHepatitis B virus
dc.subjectOccult hepatitis B and human immunodeficiency virus co-infection
dc.subjectChronic hepatitis B
dc.subjectMetabolic-dysfunction associated steatotic liver disease
dc.subjectAcute hepatitis B
dc.subjectAcute liver failure
dc.subject.classificationVirology
dc.subject.classificationMicrobiology
dc.subject.classificationImmunology
dc.subject.classificationBiology--Molecular
dc.titleInvestigating the Unique Immunological and Virological Characteristics of Hepatitis B in Special Populations
dc.typedoctoral thesis
thesis.degree.disciplineMedicine – Microbiology & Infectious Diseases
thesis.degree.grantorUniversity of Calgary
thesis.degree.nameDoctor of Philosophy (PhD)
ucalgary.thesis.accesssetbystudentI do not require a thesis withhold – my thesis will have open access and can be viewed and downloaded publicly as soon as possible.
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ucalgary_2024_patel_nishi.pdf
Size:
13.19 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.62 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Theses and Dissertations